These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 717102)

  • 1. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 1-alpha-hydroxycholecalciferol on the renal handling of phosphate in parathyroidectomized man.
    Madsen S; Olgaard K; Thaysen JH
    Acta Med Scand; 1977; 202(1-2):23-6. PubMed ID: 899879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Alpha-hydroxycholecalciferol-induced changes in the renal heandling of phosphate and the serum parathyroid hormone level.
    Madsen S; Olgaard K; Ladefoged J
    Acta Med Scand; 1976; 200(5):351-4. PubMed ID: 983805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The maximal tubular reabsorption of phosphate in relation to serum parathyroid hormone.
    Madsen S; Olgaard K; Ladefoged J
    Adv Exp Med Biol; 1977; 81():141-8. PubMed ID: 899923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling of phosphate in relation to serum parathyroid hormone levels.
    Madsen S; Olgaard K; Ladefoged J
    Acta Med Scand; 1976; 200(1-2):7-10. PubMed ID: 785962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
    Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
    Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the renal tubular effects of vitamin D by cycloheximide in the rat.
    Brezis M; Wald H; Shilo R; Popovtzer MM
    Pflugers Arch; 1983 Aug; 398(3):247-52. PubMed ID: 6688870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine does not interfere with the antiphosphaturic effect of 25(OH) vitamin D3 in the rat.
    Friedlaender MM; Wald H; Kopolovic J; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(2-3):103-9. PubMed ID: 2837627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
    Phelps KR; Mason DL
    Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of alendronate on renal tubular reabsorption of phosphate.
    Vasikaran SD; O'Doherty DP; McCloskey EV; Gertz B; Kahn S; Kanis JA
    Bone Miner; 1994 Oct; 27(1):51-6. PubMed ID: 7849546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ; Ritter CS; Knutson JC; Strugnell SA
    Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
    J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in renal tubular phosphate handling in children with sickle cell disease.
    Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G
    Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
    Hirschel-Scholz S; Caverzasio J; Bonjour JP
    J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin modulates the stimulation of renal 1,25-dihydroxyvitamin D3 production by parathyroid hormone.
    Wongsurawat N; Armbrecht HJ
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):243-8. PubMed ID: 3893009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct phenotype of kidney stone formers with renal phosphate leak.
    Dhayat NA; Lüthi D; Schneider L; Mattmann C; Vogt B; Fuster DG
    Nephrol Dial Transplant; 2019 Jan; 34(1):129-137. PubMed ID: 29939320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.